Larotrectinib (Vitrakvi, BAY2757556)

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Expanded Access to Provide Larotrectinib for the Treatment of Cancers With a NTRK Gene Fusion

NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes

A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database